These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 15036190)
21. Liver resection for metastatic colorectal cancer: assessing the risk of occult irresectable disease. Jarnagin WR; Fong Y; Ky A; Schwartz LH; Paty PB; Cohen AM; Blumgart LH J Am Coll Surg; 1999 Jan; 188(1):33-42. PubMed ID: 9915240 [TBL] [Abstract][Full Text] [Related]
22. Positron Emission Tomography Combined With Computed Tomography vs. No Positron Emission Tomography Combined With Computed Tomography for the Management of Patients With Resectable Colorectal Cancer Liver Metastases and Synchronous Extrahepatic Disease. Serrano PE; Gu CS; Moulton CA; Gallinger S Am Surg; 2021 Sep; 87(9):1431-1437. PubMed ID: 33345573 [TBL] [Abstract][Full Text] [Related]
23. Impact of 18F-FDG-positron emission tomography for decision making in colorectal cancer recurrences. Imdahl A; Reinhardt MJ; Nitzsche EU; Mix M; Dingeldey A; Einert A; Baier P; Farthmann EH Langenbecks Arch Surg; 2000 Mar; 385(2):129-34. PubMed ID: 10796051 [TBL] [Abstract][Full Text] [Related]
24. Clinical impact of 18F-FDG-PET in the suspicion of recurrent colorectal cancer based on asymptomatically elevated serum level of carcinoembryonic antigen (CEA) in Taiwan. Shen YY; Liang JA; Chen YK; Tsai CY; Kao CH Hepatogastroenterology; 2006; 53(69):348-50. PubMed ID: 16795969 [TBL] [Abstract][Full Text] [Related]
25. Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Ramos E; Valls C; Martinez L; Lladó L; Torras J; Ruiz S; Gamez C; Serrano T; Fabregat J; Rafecas A Ann Surg Oncol; 2011 Sep; 18(9):2654-61. PubMed ID: 21431987 [TBL] [Abstract][Full Text] [Related]
26. The role of positron emission tomography with fluorine-18-deoxyglucose in identifying colorectal cancer metastases to liver. Zhuang H; Sinha P; Pourdehnad M; Duarte PS; Yamamoto AJ; Alavi A Nucl Med Commun; 2000 Sep; 21(9):793-8. PubMed ID: 11065150 [TBL] [Abstract][Full Text] [Related]
27. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Selzner M; Hany TF; Wildbrett P; McCormack L; Kadry Z; Clavien PA Ann Surg; 2004 Dec; 240(6):1027-34; discussion 1035-6. PubMed ID: 15570208 [TBL] [Abstract][Full Text] [Related]
28. Colorectal cancer recurrence in the liver: detection by PET. Yasuda S; Makuuchi Y; Sadahiro S; Mukai M; Tokunaga N; Tajima T; Shohtsu A Tokai J Exp Clin Med; 1998 Oct; 23(4):167-71. PubMed ID: 10359505 [TBL] [Abstract][Full Text] [Related]
29. The use of 18F-FDG PET/CT in colorectal liver metastases--comparison with CT and liver MRI. Kong G; Jackson C; Koh DM; Lewington V; Sharma B; Brown G; Cunningham D; Cook GJ Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1323-9. PubMed ID: 18347794 [TBL] [Abstract][Full Text] [Related]
30. The role of FDG PET/CT in patients with colorectal cancer metastases. Kochhar R; Liong S; Manoharan P Cancer Biomark; 2010; 7(4):235-48. PubMed ID: 21576816 [TBL] [Abstract][Full Text] [Related]
32. Preoperative FDG-PET-scan in patients with resectable colorectal liver metastases does not improve overall survival: a retrospective analyses stratified by clinical risk score. Ayez N; de Ridder J; Wiering B; Oyen WJ; de Wilt JH; Verhoef C Dig Surg; 2013; 30(4-6):451-8. PubMed ID: 24458160 [TBL] [Abstract][Full Text] [Related]
33. Value of 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent colorectal cancer. Hung GU; Shiau YC; Tsai SC; Chao TH; Ho YJ; Kao CH Anticancer Res; 2001; 21(2B):1375-8. PubMed ID: 11396217 [TBL] [Abstract][Full Text] [Related]
34. Usefulness of intraoperative sonography for revealing hepatic metastases from colorectal cancer in patients selected for surgery after undergoing FDG PET. Rydzewski B; Dehdashti F; Gordon BA; Teefey SA; Strasberg SM; Siegel BA AJR Am J Roentgenol; 2002 Feb; 178(2):353-8. PubMed ID: 11804891 [TBL] [Abstract][Full Text] [Related]
35. Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI. Wong CY; Salem R; Raman S; Gates VL; Dworkin HJ Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):815-20. PubMed ID: 12029557 [TBL] [Abstract][Full Text] [Related]
36. The added value of dual-time-point 18F-FDG PET/CT imaging in the diagnosis of colorectal cancer liver metastases. Mao W; Zhou J; Qiu L; Yin H; Tan H; Shi H Abdom Radiol (NY); 2020 Apr; 45(4):1075-1081. PubMed ID: 31927618 [TBL] [Abstract][Full Text] [Related]
37. Prognostic value of metabolic parameters in patients with synchronous colorectal cancer liver metastasis following curative-intent colorectal and hepatic surgery. Lee HS; Kim HO; Hong YS; Kim TW; Kim JC; Yu CS; Kim JS J Nucl Med; 2014 Apr; 55(4):582-9. PubMed ID: 24549284 [TBL] [Abstract][Full Text] [Related]